Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Postgraduate Medicine
|
May 1, 1999
What to do when you discover testicular cancer. Helping patients overcome fear and choose treatment
G Sonpavde, L H Einhorn
British Journal of Cancer
|
September 6, 2012
Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma
G Sonpavde, T K Choueiri
Cancer Research
|
April 15, 2000
Antileukemic activity of Flt3 ligand in murine leukemia
A Wang, S E Braun, G Sonpavde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2014
New agents for prostate cancer
N Agarwal, G Di Lorenzo, G Sonpavde, et al.
British Journal of Cancer
|
October 29, 2014
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
P Ghatalia, Y Je, M D Kaymakcalan, et al.
Prostate Cancer and Prostatic Diseases
|
September 28, 2016
Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer
G Sonpavde, G R Pond, A J Templeton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2013
Penile cancer: current therapy and future directions
G Sonpavde, L C Pagliaro, C Buonerba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2015
Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis
D Raggi, R Miceli, G Sonpavde, et al.
American Journal of Clinical Oncology
|
February 22, 2000
Phase II study of doxorubicin and paclitaxel as second-line chemotherapy of small-cell lung cancer: a Hoosier Oncology Group Trial
G Sonpavde, R Ansari, P Walker, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
October 14, 2010
Tissue-based molecular markers for bladder cancer
C E Barbieri, Y Lotan, R K Lee, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Postgraduate Medicine
|
May 1, 1999
What to do when you discover testicular cancer. Helping patients overcome fear and choose treatment
G Sonpavde, L H Einhorn
British Journal of Cancer
|
September 6, 2012
Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma
G Sonpavde, T K Choueiri
Cancer Research
|
April 15, 2000
Antileukemic activity of Flt3 ligand in murine leukemia
A Wang, S E Braun, G Sonpavde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2014
New agents for prostate cancer
N Agarwal, G Di Lorenzo, G Sonpavde, et al.
British Journal of Cancer
|
October 29, 2014
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors
P Ghatalia, Y Je, M D Kaymakcalan, et al.
Prostate Cancer and Prostatic Diseases
|
September 28, 2016
Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer
G Sonpavde, G R Pond, A J Templeton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2013
Penile cancer: current therapy and future directions
G Sonpavde, L C Pagliaro, C Buonerba, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 22, 2015
Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis
D Raggi, R Miceli, G Sonpavde, et al.
American Journal of Clinical Oncology
|
February 22, 2000
Phase II study of doxorubicin and paclitaxel as second-line chemotherapy of small-cell lung cancer: a Hoosier Oncology Group Trial
G Sonpavde, R Ansari, P Walker, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
October 14, 2010
Tissue-based molecular markers for bladder cancer
C E Barbieri, Y Lotan, R K Lee, et al.
Page
of 3